Boehringer Reports Strong H1 2026 Sales
INGELHEIM, Germany, July 15, 2026 Boehringer Ingelheim reported strong financial and operational performance for the first half of 2026,...
Prescription, Generic, and Over-The-Counter: Drugs & Products.
BioMarin FDA Accepts VOXZOGO sNDA for Full Approval
SAN RAFAEL, Calif., July 13, 2026 BioMarin Pharmaceutical Inc. has reached a significant regulatory milestone after the U.S. Food...
Eisai Advances Alzheimer’s Care with LEQEMBI IQLIK Approval
TOKYO, Japan & CAMBRIDGE, Mass., July 13, 2026 Eisai Co., Ltd. and Biogen Inc. have achieved a major regulatory...
GSK’s Jemperli Shows Breakthrough Results in Rectal Cancer
LONDON, United Kingdom, July 13, 2026 GSK has announced positive interim results from the registrational Phase II AZUR-1 clinical...
Lighthouse Pharma Reports Breakthrough Alzheimer’s Trial Results
NOVATO, California, July 13, 2026 Lighthouse Pharmaceuticals has announced new clinical findings from its Phase 2/3 GAIN trial, demonstrating...
Tonix Pharmaceuticals Secures Major Medicare Coverage Agreement for TONMYA
BERKELEY HEIGHTS, N.J., July 13, 2026 Tonix Pharmaceuticals announced a major managed Medicare payer agreement that will expand pharmacy...
Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
ANI Reports Positive Phase 4 ILUVIEN Trial Results
PRINCETON, N.J., July 13, 2026 ANI Pharmaceuticals announced positive six-month topline results from the Phase 4, open-label, single-arm SYNCHRONICITY...
Bristol Myers Squibb NDA for Mezigdomide Accepted by FDA
PRINCETON, New Jersey, July 13, 2026 Bristol Myers Squibb (BMS) has announced that the U.S. Food and Drug Administration...
Santhera Expands AGAMREE Distribution Across Central Asia and Caucasus
PRATTELN, Switzerland, July 13, 2026 Santhera Pharmaceuticals announced the expansion of its exclusive distribution agreement with Biomedica, extending commercial...